» Articles » PMID: 6812550

Mutagenicity Tests with Astemizole in Vitro and in Vivo

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 1982 Jul 1
PMID 6812550
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Possible induction of chromosomal aberrations and/or sister chromatid exchanges by astemizole was studied in vitro on human lymphocytes. In vivo chromosomal damage was assessed by a micronucleus test on rats and a dominant lethal test on both male and female mice. All these tests yielded negative results for astemizole so that is can be concluded that astemizole has no potential to induce chromosomal aberrations.

Citing Articles

Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.

Richards D, Brogden R, Heel R, Speight T, Avery G Drugs. 1984; 28(1):38-61.

PMID: 6204835 DOI: 10.2165/00003495-198428010-00003.

References
1.
HAM R . An improved nutrient solution for diploid Chinese hamster and human cell lines. Exp Cell Res. 1963; 29:515-26. DOI: 10.1016/s0014-4827(63)80014-2. View

2.
Generoso W . Chemical induction of dominant lethals in female mice. Genetics. 1969; 61(2):461-70. PMC: 1212171. DOI: 10.1093/genetics/61.2.461. View

3.
Fabry L, Roberfroid M . Mutagenicity of aflatoxin B1: observations in vivo and their relation to in vitro activation. Toxicol Lett. 1981; 7(3):245-50. DOI: 10.1016/0378-4274(81)90076-x. View

4.
Brittinger D . [The mutagenic effect of endoxan on the mouse]. Humangenetik. 1966; 3(2):156-65. DOI: 10.1007/BF00291296. View

5.
Ames B, McCann J, Yamasaki E . Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975; 31(6):347-64. DOI: 10.1016/0165-1161(75)90046-1. View